Trademark: 98023354
Word
REFRAME
Status Date
Tuesday, May 21, 2024
Filing Date
Thursday, June 1, 2023
Published for Opposition
Tuesday, May 21, 2024
42 Medical scientific research, medical scientific development, and medical scientific testing of antibody-drug conjugates and cancer therapies; Providing medical scientific research information in the field of antibody-drug conjugates and cancer therapies; Scientific investigations for medical purposes featuring clinical trials
The mark consists of the word "Reframe" where the letter "a" is represented by the Greek character alpha.
Color is not claimed as a feature of the mark.
Jun 5, 2023
New Application Entered
Jul 5, 2023
New Application Office Supplied Data Entered
Dec 19, 2023
Assigned To Examiner
Dec 19, 2023
Non-Final Action Written
Dec 19, 2023
Non-Final Action E-Mailed
Dec 19, 2023
Notification Of Non-Final Action E-Mailed
Mar 19, 2024
Correspondence Received In Law Office
Mar 19, 2024
Teas Response To Office Action Received
Mar 19, 2024
Teas/Email Correspondence Entered
Apr 16, 2024
Approved For Pub - Principal Register
May 1, 2024
Notification Of Notice Of Publication E-Mailed
May 21, 2024
Published For Opposition
May 21, 2024
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
